TLSI Q4 2022 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3M+25.7% YoY

Gross Profit

$2M74.7% margin

Operating Income

-$12M-364.9% margin

Net Income

-$23M-698.8% margin

EPS (Diluted)

$-0.76

QoQ Revenue Growth

-17.8%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$117,000

Balance Sheet

Total Assets

$22M

Total Liabilities

$34M

Stockholders' Equity

-$12M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+25.7%
Gross Profit	$2M	$3M	-4.8%
Operating Income	-$12M	-$6M	-85.8%
Net Income	-$23M	-$7M	-223.8%